SCHEDULE: JPMorgan Chase Discloses 7% Stake in uniQure N.V.

JPMorgan Chase & Co. has reported beneficial ownership of 7.0% of uniQure N.V.'s ordinary shares as of June 30, 2026.

Summary

• JPMorgan Chase & Co. has filed a Schedule 13G, indicating it beneficially owns 4,866,211 ordinary shares of uniQure N.V.
• This represents 7.0% of the total class of securities.
• The filing was made on July 16, 2026, with the event date requiring the filing being June 30, 2026.
• JPMorgan Chase & Co. is identified as a 'HC' (likely referring to a financial institution type) and is organized in Delaware.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. It is a standard disclosure of beneficial ownership by a financial institution and does not contain operational or financial performance data that would indicate a positive or negative sentiment.

Positives

• JPMorgan Chase & Co. has a significant beneficial ownership stake of 7.0% in uniQure N.V., indicating confidence or investment activity.
• The filing confirms that the securities were acquired and are held in the ordinary course of business, suggesting standard investment practices.

Risks

• The filing does not explicitly mention any risks associated with the ownership stake or the company's operations.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding future performance or strategy.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."
• "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct."

Industry Context

StockSavvy.ai notes that this Schedule 13G filing by JPMorgan Chase & Co. indicates a significant institutional investment in uniQure N.V., a company operating in the gene therapy sector. Such filings often signal a substantial position taken by a major financial institution, which can influence market perception and potentially attract further investor interest.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a major financial institution like JPMorgan Chase & Co. may be viewed positively by some shareholders, potentially indicating institutional confidence in the company's prospects. However, it does not directly impact current operations or immediate shareholder value.
• Creditors: No direct impact is indicated.
• Employees: No direct impact is indicated.
• Suppliers: No direct impact is indicated.
• Customers: No direct impact is indicated.

Next Steps

• JPMorgan Chase & Co. will continue to hold the reported shares in the ordinary course of business.
• Further filings may be required if ownership levels change significantly.

Key Dates

Keywords

uniQure N.V., JPMorgan Chase & Co., Schedule 13G, Beneficial Ownership, Ordinary Shares, SEC Filing, Investment, Financial Institution